Elevated circulating homocysteine concentrations delayed nerve conduction velocity and increase the risk of diabetic kidney disease in patients with type 2 diabetes
The clinical assessment of homocysteine in diabetic patients holds significant importance in the prevention of microvascular complications. Lowering HCY levels may offer a promising therapeutic approach for managing microvascular disease in diabetes.
Authors
- Jinsong Kuang (ORCID: https://orcid.org/0000-0002-3164-2570)
- Xin Chen (ORCID: https://orcid.org/0009-0008-8427-3001)
- Nannan Lv (ORCID: https://orcid.org/0000-0003-2802-5253)
- Feng Liu (ORCID: https://orcid.org/0000-0003-3228-0943)
- Luzhu Jia
- Lan Cheng (ORCID: https://orcid.org/0000-0002-2679-3446)
- Fei Liu (ORCID: https://orcid.org/0009-0005-0576-440X)
Institutions
- Dalian Medical University (CN)
- The Fourth People's Hospital (CN)
- Shenyang The Fourth Hospital of People (CN)
- China Medical University (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2024-12-11
- DOI
- https://doi.org/10.3389/fendo.2024.1451758
- Citations
- 3
- Primary Topic
- Adenosine and Purinergic Signaling
- Type
- article
- Field-Weighted Citation Impact
- 1.21